News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
28,301 Results
Type
Article (3718)
Company Profile (6)
Press Release (24577)
Section
Business (10342)
Career Advice (99)
Deals (1516)
Drug Delivery (14)
Drug Development (4004)
Employer Resources (15)
FDA (809)
Job Trends (851)
News (16241)
Policy (1538)
Tag
2024 Biotech Bay Standard (2)
2024 Genetown Standard (1)
Academia (111)
Allergies (6)
Alliances (2303)
ALS (4)
Alzheimer's disease (23)
Antibody-drug conjugate (ADC) (9)
Approvals (813)
Artificial intelligence (9)
Bankruptcy (15)
Best Places to Work (538)
BIOSECURE Act (2)
Biosimilars (15)
Biotechnology (3)
Brain cancer (2)
Breast cancer (20)
Cancer (88)
Cardiovascular disease (15)
Career advice (76)
Career pathing (1)
CAR-T (8)
Cell therapy (18)
Cervical cancer (1)
Clinical research (3078)
Collaboration (35)
Compensation (9)
Complete response letters (1)
COVID-19 (331)
CRISPR (1)
C-suite (27)
Data (39)
Depression (2)
Diabetes (8)
Diagnostics (139)
Digital health (1)
Diversity, equity & inclusion (3)
Drug discovery (11)
Drug pricing (21)
Drug shortages (1)
Earnings (2764)
Editorial (7)
Employer branding (7)
Employer resources (14)
Events (2618)
Executive appointments (64)
FDA (843)
Featured Employer (2)
Funding (30)
Gene editing (3)
Generative AI (2)
Gene therapy (21)
GLP-1 (58)
Government (337)
Guidances (4)
Healthcare (612)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (6)
Indications (1)
Infectious disease (333)
Inflammatory bowel disease (1)
Inflation Reduction Act (3)
Influenza (4)
Intellectual property (2)
Interviews (17)
IPO (484)
IRA (12)
Job creations (332)
Job search strategy (76)
Labor market (1)
Layoffs (66)
Legal (407)
Liver cancer (3)
Lung cancer (7)
Lymphoma (2)
Management (3)
Manufacturing (13)
Medical device (300)
Medtech (300)
Mergers & acquisitions (1031)
Metabolic disorders (25)
Multiple sclerosis (4)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (38)
NextGen: Class of 2025 (300)
Non-profit (104)
Northern California (69)
Now hiring (2)
Obesity (16)
Opinion (40)
Pain (1)
Pancreatic cancer (1)
Parkinson's disease (2)
Patents (15)
Patient recruitment (2)
Peanut (4)
People (4536)
Pharmaceutical (2)
Phase I (909)
Phase II (1386)
Phase III (1288)
Pipeline (37)
Podcasts (9)
Policy (19)
Postmarket research (178)
Preclinical (333)
Press Release (1)
Prostate cancer (12)
Radiopharmaceuticals (32)
Rare diseases (12)
Real estate (274)
Recruiting (6)
Regulatory (916)
Reports (3)
Research institute (113)
Resumes & cover letters (24)
Schizophrenia (3)
Series A (13)
Series B (4)
Sickle cell disease (4)
Southern California (47)
Special edition (5)
Sponsored (3)
Startups (341)
Stomach cancer (1)
Supply chain (7)
The Weekly (9)
United States (474)
Vaccines (79)
Venture capitalists (6)
Webinars (2)
Weight loss (13)
Women's health (1)
Date
Today (2)
Last 7 days (21)
Last 30 days (100)
Last 365 days (1345)
2025 (228)
2024 (1347)
2023 (1381)
2022 (3315)
2021 (2709)
2020 (2269)
2019 (1812)
2018 (1392)
2017 (1681)
2016 (1299)
2015 (1489)
2014 (1161)
2013 (904)
2012 (1048)
2011 (1020)
2010 (1021)
Location
Africa (59)
Alabama (1)
Arizona (3)
Asia (1605)
Australia (238)
California (144)
Canada (101)
China (9)
Colorado (2)
Connecticut (6)
Delaware (7)
Europe (5779)
Florida (11)
Idaho (3)
Illinois (8)
Indiana (8)
Iowa (1)
Japan (1)
Kansas (1)
Kentucky (1)
Maryland (27)
Massachusetts (114)
Michigan (2)
Minnesota (3)
Nebraska (1)
Nevada (1)
New Hampshire (4)
New Jersey (35)
New Mexico (1)
New York (29)
North Carolina (26)
Northern California (69)
Ohio (3)
Pennsylvania (22)
Puerto Rico (1)
Rhode Island (1)
South America (85)
South Dakota (1)
Southern California (47)
Tennessee (1)
Texas (10)
Virginia (1)
Washington D.C. (3)
Washington State (7)
Wisconsin (1)
28,301 Results for "nova".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
December 31, 2024
·
7 min read
Press Releases
Nova Scotia shows leadership in publicly reimbursing Pluvicto™ for eligible patients with advanced prostate cancer
February 4, 2025
·
4 min read
Press Releases
Proteomics Market to Reach USD 95.81 Billion to 2034 - Exclusive Report by Nova one advisor
February 7, 2025
·
1 min read
Press Releases
Truvian Health Appoints Dr. Tina Nova to its Board of Directors
December 11, 2024
·
2 min read
Press Releases
Psoriasis Drugs Market to Reach USD 59.77 Billion to 2034 - Exclusive Report by Nova one advisor
December 13, 2024
·
1 min read
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
Dexcom, Inc., a global leader in real-time continuous glucose monitoring for people with diabetes, announced that residents of Nova Scotia living with either type 1 or type 2 diabetes who use intensive insulin and meet eligibility criteria now have coverage for Dexcom G6 and Dexcom G7 continuous glucose monitoring systems.
June 3, 2024
·
4 min read
Press Releases
Nova Mentis Assigns Intellectual Property
August 27, 2024
·
3 min read
Press Releases
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer
December 6, 2024
·
5 min read
Press Releases
Centinel Spine® Extends Leadership in Total Disc Replacement through First U.S. Use of prodisc® C Nova, the Fourth prodisc Cervical Design
November 1, 2024
·
4 min read
Policy
Nova Mentis Applauds Government Decision to Create Rare Disease Advisory Group
Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is pleased the Canadian government has established a new Implementation Advisory Group
November 3, 2023
·
3 min read
1 of 2,831
Next
